Cerestat: Began two Phase Ib trials

Cambridge NeuroScience Inc. (CNSI) Product: Cerestat, N-methyl-D-aspartate (NMDA) ion-channel blocker Indication: Traumatic brain injury Status: Began two Phase Ib trials in the U.S. and Scotland ...